Thrivent Financial For Lutherans grew its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 6.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,285 shares of the medical instruments supplier’s stock after buying an additional 1,770 shares during the quarter. Thrivent Financial For Lutherans owned approximately 0.06% of Merit Medical Systems worth $1,155,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. BlackRock Inc. lifted its position in Merit Medical Systems by 7,837.9% during the 1st quarter. BlackRock Inc. now owns 6,789,527 shares of the medical instruments supplier’s stock worth $196,218,000 after buying an additional 6,703,994 shares in the last quarter. Vanguard Group Inc. lifted its position in Merit Medical Systems by 16.1% during the 1st quarter. Vanguard Group Inc. now owns 4,186,883 shares of the medical instruments supplier’s stock worth $121,001,000 after buying an additional 580,871 shares in the last quarter. Frontier Capital Management Co. LLC lifted its position in Merit Medical Systems by 24.8% during the 2nd quarter. Frontier Capital Management Co. LLC now owns 2,737,303 shares of the medical instruments supplier’s stock worth $104,428,000 after buying an additional 543,580 shares in the last quarter. State Street Corp lifted its position in Merit Medical Systems by 1.7% during the 1st quarter. State Street Corp now owns 1,218,788 shares of the medical instruments supplier’s stock worth $35,223,000 after buying an additional 20,885 shares in the last quarter. Finally, Macquarie Group Ltd. lifted its position in Merit Medical Systems by 1.5% during the 1st quarter. Macquarie Group Ltd. now owns 1,000,319 shares of the medical instruments supplier’s stock worth $28,909,000 after buying an additional 15,255 shares in the last quarter. 89.11% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have commented on MMSI shares. Citigroup Inc. cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price target on the stock. in a research report on Monday, August 28th. They noted that the move was a valuation call. BidaskClub raised shares of Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 27th. Zacks Investment Research cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday. Canaccord Genuity reissued a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a research report on Wednesday, September 6th. Finally, Raymond James Financial, Inc. reissued an “outperform” rating and set a $44.00 price target on shares of Merit Medical Systems in a research report on Monday, August 28th. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. Merit Medical Systems has a consensus rating of “Buy” and a consensus target price of $41.27.

Shares of Merit Medical Systems, Inc. (NASDAQ MMSI) opened at 45.40 on Friday. The company has a market capitalization of $2.28 billion, a PE ratio of 64.67 and a beta of 1.25. Merit Medical Systems, Inc. has a 12 month low of $20.70 and a 12 month high of $45.40. The firm’s 50-day moving average is $41.56 and its 200 day moving average is $36.53.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The business had revenue of $186.50 million during the quarter, compared to the consensus estimate of $181.46 million. During the same quarter last year, the company posted $0.26 earnings per share. The firm’s quarterly revenue was up 23.4% compared to the same quarter last year. Equities research analysts predict that Merit Medical Systems, Inc. will post $1.26 EPS for the current year.

In related news, insider Richard W. Edelman sold 29,000 shares of the firm’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $41.19, for a total transaction of $1,194,510.00. Following the completion of the sale, the insider now owns 35,000 shares in the company, valued at $1,441,650. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kent W. Stanger sold 670 shares of the firm’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $42.06, for a total transaction of $28,180.20. The disclosure for this sale can be found here. Insiders have sold 67,106 shares of company stock valued at $2,772,344 in the last 90 days. 5.00% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: “Thrivent Financial For Lutherans Boosts Position in Merit Medical Systems, Inc. (MMSI)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.thecerbatgem.com/2017/10/06/thrivent-financial-for-lutherans-boosts-position-in-merit-medical-systems-inc-mmsi.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.